Cbl-b Is a Negative Regulator of Inflammatory Cytokines Produced by IgE-Activated Mast Cells
Open Access
- 1 November 2006
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 177 (9) , 5980-5989
Abstract
C-Cbl and Cbl-b E3 ubiquitin ligases are abundantly expressed in hemopoietic cells where they negatively regulate the activity and levels of many cell surface receptors and associated signaling molecules. By comparing bone marrow-derived mast cells from c-Cbl and Cbl-b-deficient mice it has recently been shown that Cbl-b is the dominant family member for negatively regulating signaling responses from high-affinity IgE receptors. In this study, we suggest that a possible reason for the greater enhancement of IgE receptor signaling in Cbl-b-deficient mice is the relatively higher levels of Cbl-b protein over c-Cbl in mast cells compared with other hemopoietic cells. We also directly compare mast cells from c-Cbl and Cbl-b-deficient mice and find that loss of Cbl-b, but not c-Cbl, increases cell growth, retards receptor internalization, and causes the sustained tyrosine phosphorylation of Syk and its substrates. However, loss of Cbl-b does not enhance the activation of ERK or Akt, nor does it promote a greater calcium response. Furthermore, loss of Cbl-b or c-Cbl does not increase levels of the Syk or Lyn protein tyrosine kinases. Most notable, however, is the extremely large increase in the production of proinflammatory cytokines TNF-α, IL-6, and MCP-1 by Cbl-b−/− mast cells compared with levels produced by c-Cbl−/− or wild-type cells. This marked induction, which appears to be restricted to these three cytokines, is dependent on IgE receptor activation and correlates with enhanced IκB kinase phosphorylation. Thus, Cbl-b functions as a potent negative regulator of cytokines that promote allergic and inflammatory reactions.Keywords
This publication has 55 references indexed in Scilit:
- The Bcl10–Malt1 complex segregates FcεRI-mediated nuclear factor κB activation and cytokine production from mast cell degranulationJournal of Experimental Medicine, 2006
- The Cbl interactome and its functionsNature Reviews Molecular Cell Biology, 2005
- Selective Inhibition of FcεRI-Mediated Mast Cell Activation by a Truncated Variant of Cbl-b Related to the Rat Model of Type 1 Diabetes MellitusThe Journal of Biochemistry, 2005
- Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-IκB-NF-κB pathway in IgE-dependent mast cell activationJournal of Leukocyte Biology, 2005
- Positive and Negative Regulation of FcεRI-Mediated Signaling by the Adaptor Protein LAB/NTALJournal of Experimental Medicine, 2004
- Negative Regulation of Mast Cell Signaling and Function by the Adaptor LAB/NTALJournal of Experimental Medicine, 2004
- Negative regulation of FcϵRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-bBlood, 2004
- A Mouse with a Loss-of-function Mutation in the c-Cbl TKB Domain Shows Perturbed Thymocyte Signaling without Enhancing the Activity of the ZAP-70 Tyrosine KinaseJournal of Experimental Medicine, 2003
- Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulationNature Immunology, 2002
- A Positive Regulatory Role for Cbl Family Proteins in Tumor Necrosis Factor-related Activation-induced Cytokine (TRANCE) and CD40L-mediated Akt ActivationJournal of Biological Chemistry, 2001